Iranian Knowledge-Based Firm Produces, Commercializes Embryo Culture Environment
“We fully produce embryo culture mediums for one to five days,” said Taheri, an embryologist working for the knowledge-based company.
“Embryo culture environment is a single-stage model that covers a one-day-old embryo to a five-day-old embryo, and the other environment produced by the company is a two-stage embryo culture,” he added.
In a relevant development earlier in May, an Iranian knowledge-based company active in the field of stem cells gained the capability to process all types of immune and blood cells for cancer treatment and early detection of drug resistance in cancer patients.
“Our company is a leading firm in production of advanced cellular products with the aim of providing cellular services based on immune cells, hematopoietic cells, and genetically modified cells,” said Marzieh Ebrahimi, the managing-director of Kian Eimen Selloul company.
“In addition to having the approval of the Food and Drug Administration of Iran, our company is the first holder of the international medical equipment standard certificate ISO13485:2016 and the ISO9001:2015 for quality management system in the field of isolation of natural killer cells from peripheral blood for the purpose of cancer treatment and early detection of drug resistance in patients,” she added.
“The company also enjoys the necessary capability of processing all types of immune cells and blood cells for treatment, gene changes in blood cells with therapeutic purposes and providing consulting services,” Ebrahimi said.
4155/v
